ChromaDex's website homepage. Credit: Pavel Kapysh/Shutterstock.com 'All About the Wording': In Row Between Biosciences Companies, Federal Jury Rejects Trade Secrets Claims
Split verdict sides mostly with Elysium, and against its supplier ChromaDex.
September 28, 2021 at 04:52 PM
7 minute read
Biotechnology
A federal jury Monday night awarded bioscience company Elysium Health $2 million in its five-year battle with its former supplier ChromaDex, rejecting all trade secrets claims brought by ChromaDex while embracing Elysium's counter-narrative about a plot by billionaire pharmaceutical investor Phil Frost.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All
Los Angeles Secures $35M Settlement From Monsanto in Water Contamination Lawsuit
After Guiding Illumina Through Harrowing Merger Fight, GC Charles Dadswell to Depart
Who Got the Work: O'Melveny Set to Defend Abbott Labs in Digital Privacy Class Action
Who Got the Work: Quinn Emanuel and Irell & Manella Appear in Trade Secrets Case
3 minute readLaw Firms Mentioned
Trending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
- 3Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5A RICO Surge Is Underway: Here's How the Allstate Push Might Play Out
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
